Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-02-23 @ 6:24 AM
Study NCT ID:
NCT01282632
Status:
COMPLETED
Last Update Posted:
2011-01-25
First Post:
2011-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression
Sponsor:
Sunnybrook Health Sciences Centre
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Subjects Had Unipolar, Non-psychotic Major Depression | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | depression | View |
| None | treatment resistant depression | View |
| None | unipolar | View |
| None | non- psychotic major depression | View |
| None | add-on to a serotonin type antidepressants | View |
| None | risperidone | View |
| None | olanzapine | View |
| None | double blind comparison | View |
| None | randomized | View |